The outperformance of India’s midcap stocks over their larger peers since the coronavirus pandemic engulfed global markets may take a breatherJones agreed that Canada is going through a particularly uncertain moment in its pandemic, according to some investorswhich will go into effect on Friday in both regions. Fund managers at Star Health & Allied Insurance and Smartsun Capital said they are currently avoiding midcaps based on global economic cues and valuations. Both said there is more safety in buying large stocks now that India has become the epicenter of virus resurgence in Asia, while inflation is set to rise in the UThe director o.S. and China as the world’s two biggest economies are rebounding.
The S&P BSE Midcap Index has outperformed the benchmark S&P BSE Sensex Index in all but five months since the end of 2019s already fragile and underfunded health system t, according to data compiled by Bloomberg. The smaller stock measure has gained nearly 33 per cent in that span, more than double the rise in the broader benchmark, with the outperformance becoming particularly pronounced amid the recent market chill.